Safety and Feasibility of On-the-Table Pharmacomechanical Lysis for Acute Intermediate-Risk Pulmonary Embolism: The RESCUE-II Study | JACC: Advances
Release Date: 06/25/2025
JACC Specialty Journals
Dr. Emile Daoud, Deputy Editor of JACC Clinical Electrophysiology discusses the impact of prior exercise practice on disease characteristics in Desmoplakin-related arrhythmogenic left ventricular cardiomyopathy.
info_outlineJACC Specialty Journals
Commentary by Dr. Jian'an Wang.
info_outlineJACC Specialty Journals
Commentary by Dr. Jian'an Wang.
info_outlineJACC Specialty Journals
Commentary by Dr. Jian'an Wang.
info_outlineJACC Specialty Journals
Commentary by Dr. Jian'an Wang.
info_outlineJACC Specialty Journals
Commentary by Dr. Meihan Guo.
info_outlineJACC Specialty Journals
Commentary by Dr. Jian'an Wang.
info_outlineJACC Specialty Journals
Commentary by Dr. Jian'an Wang.
info_outlineJACC Specialty Journals
Commentary by Dr. Jian'an Wang.
info_outlineJACC Specialty Journals
Audio Summary of the July 2025 Issue by Dr. Jian'an Wang.
info_outlineDarshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Safety and Feasibility of On-the-Table Pharmacomechanical Lysis for Acute Intermediate-Risk Pulmonary Embolism: The RESCUE-II Study.